Medication info
Risedronate Sodium 35 mg (Risedronate Sodium 2.5 Hydrate)

Risedronate Sodium 35 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.17mg / 1 tablet
Manufacturer / importer
Nexpam Korea Co., Ltd.
Appearance
Light orange, rectangular film-coated tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 200713889 · Notified 2007.12.31 · Insurance code 662502120

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults : Administer sodium risedronate 35 mg orally once weekly. 2. Older adults : No dose adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Since food interferes with the absorption of this medicine, for adequate absorption take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.

Ingredients

Manufacturer
Nexpam Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and for the treatment of osteoporosis in men.

How to take

Adult dose

1. Adults : Administer sodium risedronate 35 mg orally once weekly. 2. Older adults : No dose adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. ○ Since food interferes with the absorption of this medicine, for adequate absorption take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.

Precautions

This medication may irritate the gastrointestinal mucosa; therefore, caution should be taken in patients with Barrett's esophagus, dysphagia, esophageal diseases, gastritis, duodenitis, or ulcers. It should be taken with sufficient water, and patients should not lie down for at least 30 minutes after taking it. Esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosions may occur, so if symptoms such as dysphagia, odynophagia, pain behind the sternum, or heartburn occur, the medication should be stopped immediately, and a doctor should be consulted. This medication should not be administered to patients with specific esophageal abnormalities, hypocalcemia, pregnant or breastfeeding women, or those with severe renal impairment. It is important to ensure sufficient calcium and vitamin D supplementation, and caution is needed as absorption may be hindered when taken with medications or foods containing calcium, magnesium, iron, etc. Rare serious side effects such as osteonecrosis of the jaw, atypical femoral fractures, and osteonecrosis of the external auditory canal may occur with long-term use; any unusual symptoms should be reported to healthcare professionals immediately. Before administration, metabolic issues related to bones and minerals like hypocalcemia or parathyroid dysfunction and vitamin D deficiency must be treated. This medication should not be chewed or sucked and should not be taken before bed or upon waking. Pregnant or breastfeeding women should not take this medication, and its safety in children has not been established. Symptoms of hypocalcemia may appear in case of overdose, so immediate medical attention should be sought. This medication should be stored out of the reach of children and should not be transferred to other containers.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • infection
  • low back pain
  • accidental injury
  • pain
Show 60 more
  • abdominal pain
  • flu symptoms
  • headache
  • weakness
  • neck pain
  • chest pain
  • allergic reaction
  • hypertension
  • constipation
  • diarrhea
  • dyspepsia
  • nausea
  • peripheral edema
  • joint pain
  • arthritis
  • fracture
  • joint abnormality
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • vomiting
  • uveitis
  • scleritis
  • iritis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • skin reaction
  • bone pain
  • joint pain
  • myalgia
  • external ear bone necrosis
  • jawbone necrosis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • myalgia
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture intrusion, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Light orange, rectangular film-coated tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.